DK114131B - Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf. - Google Patents

Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf.

Info

Publication number
DK114131B
DK114131B DK102863AA DK102863A DK114131B DK 114131 B DK114131 B DK 114131B DK 102863A A DK102863A A DK 102863AA DK 102863 A DK102863 A DK 102863A DK 114131 B DK114131 B DK 114131B
Authority
DK
Denmark
Prior art keywords
hexahydroindane
carboxyethyl
oxo
hydroxy
methyl
Prior art date
Application number
DK102863AA
Other languages
English (en)
Inventor
G Amiard
J Cerede
G Nomine
V Torelli
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR890184A external-priority patent/FR1364556A/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK114131B publication Critical patent/DK114131B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/215Saturated compounds having only one carboxyl group and containing keto groups containing singly bound oxygen containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/80Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J61/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK102863AA 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf. DK114131B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR890184A FR1364556A (fr) 1962-03-06 1962-03-06 Nouveau procédé de synthèse de stéroïdes et de composés apparentés et produits utilisés dans ce procédé
FR957460A FR1476509A (fr) 1962-03-06 1963-12-17 Nouveau procédé de syntbèse de stéroïdes et de composés apparentés et produits utilisés dans ce procédé
FR960254A FR1512318A (fr) 1962-03-06 1964-01-14 Dérivés optiquement actifs de la 19-nor testostérone et procédé de préparation
FR964517A FR91612E (fr) 1962-03-06 1964-02-20 Dérivés optiquement actifs de la 19-nor testostérone et procédé de préparation

Publications (1)

Publication Number Publication Date
DK114131B true DK114131B (da) 1969-06-02

Family

ID=27445406

Family Applications (7)

Application Number Title Priority Date Filing Date
DK102963AA DK121224B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af δ-lacton af 1β-acyloxy-4-(2'-carboxyethyl)-5-hydroxy-7aβ-methyl-3aα, 4β,7,7a-tetrahydroindan.
DK102863AA DK114131B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf.
DK102663AA DK114687B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1,5-dioxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan.
DK103063AA DK111956B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ<9>-estren.
DK295764AA DK112032B (da) 1962-03-06 1964-06-12 Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy- eller -acyloxy-Δ<4>-estrenderivater.
DK618764A DK144794C (da) 1962-03-06 1964-12-17 Fremgangsmaade til fremstilling af d-formen af 3-oxo-17beta-hydroxy-17alfa-ethynyl-13beta-ethyl-4-gonen eller estere deraf
DK618564AA DK127062B (da) 1962-03-06 1964-12-17 Analogifremgangsmåde til fremstilling af 18-nor-13β-ethyl-estradiol eller dets estere.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK102963AA DK121224B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af δ-lacton af 1β-acyloxy-4-(2'-carboxyethyl)-5-hydroxy-7aβ-methyl-3aα, 4β,7,7a-tetrahydroindan.

Family Applications After (5)

Application Number Title Priority Date Filing Date
DK102663AA DK114687B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1,5-dioxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan.
DK103063AA DK111956B (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ<9>-estren.
DK295764AA DK112032B (da) 1962-03-06 1964-06-12 Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy- eller -acyloxy-Δ<4>-estrenderivater.
DK618764A DK144794C (da) 1962-03-06 1964-12-17 Fremgangsmaade til fremstilling af d-formen af 3-oxo-17beta-hydroxy-17alfa-ethynyl-13beta-ethyl-4-gonen eller estere deraf
DK618564AA DK127062B (da) 1962-03-06 1964-12-17 Analogifremgangsmåde til fremstilling af 18-nor-13β-ethyl-estradiol eller dets estere.

Country Status (11)

Country Link
US (1) US3413314A (da)
BE (4) BE657261A (da)
BR (5) BR6347416D0 (da)
CH (10) CH410934A (da)
DE (7) DE1468530A1 (da)
DK (7) DK121224B (da)
FR (3) FR1476509A (da)
GB (11) GB1042631A (da)
IL (6) IL30736A (da)
NL (8) NL6414755A (da)
SE (5) SE310364B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526962A (fr) * 1967-01-06 1968-05-31 Roussel Uclaf Nouveau procédé de préparation d'un composé gonatriénique et produits en résultant
US3979458A (en) * 1967-12-04 1976-09-07 Syntex Corporation Production of unsaturated carbocyclic ketones
US3855247A (en) * 1967-12-04 1974-12-17 Syntex Corp Production of unsaturated carbocyclic ketones
US3541210A (en) * 1968-04-10 1970-11-17 Sandoz Ag 17-alpha-(2-butyn-1-yl)-substituted steroids
US3929876A (en) * 1968-10-04 1975-12-30 Hoffmann La Roche Stereospecific total steroidal synthesis via substituted C/D-trans indanones
US3927031A (en) * 1968-10-04 1975-12-16 Hoffmann La Roche Stereospecific total steroidal synthesis via substituted C/D-trans indanones
US3897460A (en) * 1968-10-04 1975-07-29 Hoffmann La Roche 3{62 -Tertiarybutoxy-decahydro-benz{8 E{9 indenes
FR2183555B1 (da) * 1972-05-10 1975-06-20 Roussel Uclaf
US4158012A (en) * 1978-06-19 1979-06-12 Syntex (U.S.A.) Inc. Steroid synthesis process using mixed anhydride
US4234491A (en) 1978-06-19 1980-11-18 Syntex (U.S.A.) Inc. Steroid synthesis process using mixed anhydride
US4400524A (en) * 1981-07-28 1983-08-23 The Upjohn Company Grignard reagents prepared from 5-halopentan-2-one propylene ketals
US4900837A (en) * 1982-05-18 1990-02-13 University Of Florida Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors
US5567830A (en) * 1994-02-14 1996-10-22 Cocensys, Inc. Process for synthesis of acetylenic carbinols
DE19503327A1 (de) * 1995-02-02 1996-08-08 Basf Ag Verfahren zur Herstellung von 5-Oxo-6-heptensäurealkylestern sowie neue Zwischenprodukte zu ihrer Herstellung
IL119649A (en) * 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
ITUB20155260A1 (it) 2015-10-30 2017-04-30 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632347A (da) *
US2839537A (en) * 1952-05-12 1958-06-17 Ciba Pharm Prod Inc Tricyclic diketone and process of manufacture
US3019252A (en) * 1959-06-18 1962-01-30 Lab Francais Chimiotherapie Process for the preparation of novel derivatives of cyclopentanonaphthalene and products obtained thereby
US3115507A (en) * 1960-01-22 1963-12-24 Roussel Uclaf New analogs of 19-nor-testosterone, their esters and process of preparation
FR1363113A (fr) * 1960-07-29 1964-06-12 Roussel Uclaf Nouveaux dérivés oestradiéniques
FR1283951A (fr) * 1960-12-28 1962-02-09 Chimiotherapie Lab Franc Nouveau dérivé propylé du phénanthrène et procédé de préparation

Also Published As

Publication number Publication date
CH436275A (fr) 1967-05-31
SE310364B (da) 1969-04-28
US3413314A (en) 1968-11-26
DK127062B (da) 1973-09-17
DE1468531B1 (de) 1977-03-31
BE657260A (da)
DE1518111C3 (de) 1979-04-26
IL22636A (en) 1968-12-26
GB1042632A (en) 1966-09-14
BR6465403D0 (pt) 1973-08-02
GB1096769A (en) 1967-12-29
DE1518111A1 (de) 1972-03-16
DE1468529A1 (de) 1969-04-10
CH411858A (fr) 1966-04-30
GB1057117A (en) 1967-02-01
BE657262A (da)
CH433265A (fr) 1967-04-15
IL30735A (en) 1970-12-24
CH424768A (fr) 1966-11-30
DE1468529B2 (de) 1979-03-08
BR6465402D0 (pt) 1973-07-17
NL126395C (da)
GB1096762A (en) 1967-12-29
GB1096771A (en) 1967-12-29
CH427782A (fr) 1967-01-15
IL22637A (en) 1969-02-27
CH410934A (fr) 1966-04-15
DK112032B (da) 1968-11-04
DE1468529C3 (de) 1979-10-31
DE1468897A1 (de) 1969-01-02
IL22635A (en) 1969-01-29
DE1468896A1 (de) 1969-01-16
GB1096763A (en) 1967-12-29
SE302301B (da) 1968-07-15
DE1468530A1 (de) 1969-03-06
NL6414764A (da) 1965-06-18
DK144794B (da) 1982-06-07
BE657261A (da)
DE1468897C3 (de) 1978-07-13
GB1096768A (en) 1967-12-29
SE309038B (da) 1969-03-10
NL6414756A (da) 1965-06-18
IL22638A (en) 1969-03-27
DE1468895A1 (de) 1969-01-23
CH436274A (fr) 1967-05-31
DK121224B (da) 1971-09-27
NL6414702A (da) 1965-06-18
BR6565404D0 (pt) 1973-08-02
DK144794C (da) 1982-12-20
NL122309C (da)
CH436273A (fr) 1967-05-31
FR1476509A (fr) 1967-04-14
SE319174B (da) 1970-01-12
GB1096761A (en) 1967-12-29
FR1512318A (fr) 1968-02-09
CH437272A (fr) 1967-06-15
DK114687B (da) 1969-07-28
NL122142C (da)
DE1518111B2 (de) 1978-08-31
BR6465401D0 (pt) 1973-07-17
BE657263A (da)
IL30736A (en) 1969-01-29
FR91612E (fr) 1968-07-19
DE1468530B2 (da) 1979-03-22
DK111956B (da) 1968-10-28
SE313306B (da) 1969-08-11
GB1042631A (en) 1966-09-14
GB1096767A (en) 1967-12-29
NL6414755A (da) 1965-06-18
DE1468530C3 (da) 1979-12-20
BR6347416D0 (pt) 1973-08-28
CH450406A (fr) 1968-01-31
GB1042633A (en) 1966-09-14
NL123143C (da)

Similar Documents

Publication Publication Date Title
DK114131B (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2&#39;-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf.
DK111896B (da) Fremgangsmåde til fremstilling af methylendioxybenzen eller 1,3-benzoxathiol eller derivater deraf.
DK112093B (da) Fremgangsmåde til fremstilling af dihydroanguidin eller acylderivater heraf.
DK114058B (da) Fremgangsmåde til fremstilling af 2,4-disulfamyl-N-(3-hydroxy-2-propenyliden)-anilinderivater.
DK115916B (da) Fremgangsmåde til fremstilling af 1-(2&#39;-desoxy-D-ribofuranosyl)-5-fluor-cytosiner eller 4-N-p-toluoylderivater deraf.
DK107742C (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2&#39;-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK108971C (da) Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater.
DK104173C (da) Fremgangsmåde til fremstilling af 1,2-dimetylhexahydropyridaziner eller kvaternære ammoniumforbindelser deraf.
DK104065C (da) Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater.
DK114831B (da) Fremgangsmåde til fremstilling af hjertevirksomme 4&#39;-acylcymariner.
DK103513C (da) Fremgangsmåde til fremstilling af monomethonium- eller bis-methoniumforbindelser af 3-azabicyclo-(3,2,2)-nonanderivater.
DK103239C (da) Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon.
DK105025C (da) Fremgangsmåde til fremstilling af umættede 9,10-dihydro-10,10,-dimethylanthracenderivater eller syreadditionssalte deraf.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK104680C (da) Fremgangsmåde til fremstilling af derivater af 6-methyl-8-aminomethyl-ergolin I.
DK103025C (da) Fremgangsmåde til fremstilling af 1,4-dioxanderivater.
DK105161C (da) Fremgangsmåde til fremstilling af 3α-phenylgranatanderivater.
DK102920C (da) Fremgangsmåde til fremstilling af 1-cyancolchicinderivater.
DK115333B (da) Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater.
DK105920C (da) Fremgangsmåde til fremstilling af 3-β-hydroxyethylimino-17 α-acyloxy-20-keto-4,6-pregnadien-(eller 1,4,6-pregnatrien)-derivater.
DK103020C (da) Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner.
DK101740C (da) Fremgangsmåde til fremstilling af N-benzensulfonyl-N&#39;-cycloheptylurinstof-derivater.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ&lt;3,5&gt;-pregnadien-17α-ol-20-oner, eller 16-amino-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.